Preferred Label : Single-Domain antibodies;
MeSH definition : An immunoglobulin fragment composed of one variable domain from an IMMUNOGLOBULIN
HEAVY CHAIN or IMMUNOGLOBULIN LIGHT CHAIN.;
MeSH synonym : Single-Domain Antibody; Antibody, Single-Domain; Single Domain Antibody;
CISMeF synonym : antibodies, Single-Domain; single domain antibodies;
CISMeF acronym : sdAb;
MeSH hyponym : VNAR immunoglobulin fragments; immunoglobulin VL domain fragments; immunoglobulin VH domain fragments; VHH immunoglobulin fragments; VL Domain Fragments; Domain Fragments, VL; Fragments, VL Domain; VH Domain Fragments; Domain Fragments, VH; Fragments, VH Domain; Fragments, VHH Immunoglobulin; Immunoglobulin Fragments, VHH; Nanobodies; VHH Fragments; Fragments, VHH; Fragments, VNAR Immunoglobulin; Immunoglobulin Fragments, VNAR; VNAR Fragments; Fragments, VNAR; VHH Antibodies; VHH Antibody; Antibody, VHH;
Wikipedia link : https://en.wikipedia.org/wiki/Single-domain antibodies;
Is substance : O;
Origin ID : D061905;
UMLS CUI : C3494231;
Allowable qualifiers
Record concept(s)
Related MeSH Supplementary Concept(s)
- DMS5540 [MeSH Supplementary Concept]
See also
Semantic type(s)
An immunoglobulin fragment composed of one variable domain from an IMMUNOGLOBULIN
HEAVY CHAIN or IMMUNOGLOBULIN LIGHT CHAIN.
https://www.has-sante.fr/portail/jcms/c_2964765/fr/cablivi
2019
false
false
false
France
French
caplacizumab
orphan drug production
adult
thrombotic thrombocytopenic purpura, acquired
injections, intravenous
injections, subcutaneous
von willebrand factor
treatment outcome
evaluation of the transparency committee
caplacizumab
Single-Domain antibodies
purpura, thrombotic thrombocytopenic
---
https://www.ema.europa.eu/medicines/human/EPAR/Cablivi
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
caplacizumab
drug approval
europe
caplacizumab
orphan drug production
product surveillance, postmarketing
adult
thrombotic thrombocytopenic purpura, acquired
injections, intravenous
injections, subcutaneous
von willebrand factor
pregnancy
breast feeding
drug evaluation, preclinical
Single-Domain antibodies
caplacizumab
Single-Domain antibodies
purpura, thrombotic thrombocytopenic
---